Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Liver Cells, Insulin-producing Cells, Thymus… >

Liver Cells, Insulin-producing Cells, Thymus Can Be Grown in Lymph Nodes, Pitt Team Finds

Published: September 27, 2012.
Released by University of Pittsburgh Schools of the Health Sciences  

PITTSBURGH, Sept. 27, 2012 – Lymph nodes can provide a suitable home for a variety of cells and tissues from other organs, suggesting that a cell-based alternative to whole organ transplantation might one day be feasible, according to researchers at the University of Pittsburgh School of Medicine and its McGowan Institute for Regenerative Medicine. In a report recently published online in Nature Biotechnology, the research team showed for the first time that liver cells, thymus tissue and insulin-producing pancreatic islet cells, in an animal model, can thrive in lymph nodes despite being displaced from their natural sites.

Hepatitis virus infection, alcoholic cirrhosis and other diseases can cause so much damage that liver transplantation is the only way to save the patient, noted senior investigator Eric Lagasse, Pharm. D., Ph.D., associate professor, Department of Pathology, Pitt School of Medicine. Children with DiGeorge syndrome lack functional thymus glands to produce essential immune cells, and diabetes can be cured with a pancreas transplant.

"However, the scarcity of donor organs means many people will not survive the wait for transplantation," said Dr. Lagasse, whose lab is at the McGowan Institute. "Cell therapies are being explored, but introducing cells into tissue already ravaged by disease decreases the likelihood of successful engraftment and restoration of function."

In the study, his team tested the possibility of using lymph nodes, which are abundant throughout the body and have a rich blood supply, as a new home for cells from other organs in what is called an "ectopic" transplant.

They injected healthy liver cells from a genetically-identical donor animal into lymph nodes of mice at various locations. The result was an enlarged, liver-like node that functioned akin to the liver; in fact, a single hepatized lymph node rescued mice that were in danger of dying from a lethal metabolic liver disease. Likewise, thymus tissue transplanted into the lymph node of mice that lacked the organ generated functional immune systems, and pancreatic islet cell transplants restored normal blood sugar control in diabetic animals.

"Our goal is not necessarily to replace the entire liver, for example, but to provide sufficient cell mass to stabilize liver function and sustain the patient's life," Dr. Lagasse said. "That could buy time until a donor organ can be transplanted. Perhaps, in some cases, ectopic cell transplantation in the lymph node might allow the diseased organ to recover."




The above story is based on materials provided by University of Pittsburgh Schools of the Health Sciences.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Cells 
2/25/14 
★★★ 

New Clues Found to Preventing Lung Transplant Rejection
Liver 
4/29/10 
Study Links Liver Transplantation to Accelerated Cellular Aging
Researchers at the University of Cambridge found that liver transplant recipients develop premature immune senescence, the normal process by which the immune system ages and becomes less effective. Full …
Tolerance 
5/24/10 
Gene Pattern May Identify Kidney Transplant Recipients Who Don't Need Life-long Anti-rejection Drugs
Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped …
Liver 
9/20/11 
How Our Liver Kills 'Killer Cells'
Our livers can fight back against the immune system—reducing organ rejection but also making us more susceptible to liver disease. Scientists at the Centenary Institute in Sydney have …
Transplant 
9/15/10 
King's College London Reveals Promising Techniques for Extending the Life of an Organ Transplant
Experts from the Medical Research Council (MRC) Centre for Transplantation at King's College London, based at Guy's Hospital, have revealed exciting new scientific developments for people with an organ …
Cells 
9/1/11 
New Half-match Bone Marrow Transplant Procedure Yields Promising Outcomes for Cancer Patients
PHILADELPHIA—Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center …
Cells 
1/17/14 
New Insights into Facial Transplantation
Boston, MA—In 2009, the first face transplant was performed at Brigham and Women's Hospital (BWH), and lead surgeon, Dr. Bohdan Pomahac has been pioneering the procedure since. However, understanding …
Cells 
10/15/14 
Immune Cells in the Liver Drive Fatty Liver Disease And Liver Cancer
The results of their research have been published as the cover story of the renowned medical journal Cancer Cell. …
Viruses 
2/13/12 
Stress in Cells Activates Hepatitis Viruses
People who have received a donor organ need lifelong immunosuppressant drugs to keep their immune system from attacking the foreign tissue. However, with a suppressed immune system, many infectious …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile